Public perspective on potential treatment intervention harm in clinical trials-terminology and communication
| dc.contributor.author | Phillips, Rachel | |
| dc.contributor.author | Bi, Dongquan | |
| dc.contributor.author | Goulão, Beatriz | |
| dc.contributor.author | Miller, Marie | |
| dc.contributor.author | El-Askary, Malak | |
| dc.contributor.author | Fagbemi, Oluyemi | |
| dc.contributor.author | Freeborn, Curie | |
| dc.contributor.author | Giammetta, Maria | |
| dc.contributor.author | El Masri, Noura | |
| dc.contributor.author | Flockhart, Peter | |
| dc.contributor.author | Kumar, Manos | |
| dc.contributor.author | Melvin, Mike | |
| dc.contributor.author | Murray, Dianne | |
| dc.contributor.author | Myhill, Anthony | |
| dc.contributor.author | Saeid, Laila | |
| dc.contributor.author | Thomas, Shanice | |
| dc.contributor.author | MacLennan, Graeme | |
| dc.contributor.author | Cornelius, Victoria | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.contributor.institution | University of Aberdeen.Centre for Healthcare Randomised Trials (CHaRT) | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2024-09-02T12:45:00Z | |
| dc.date.available | 2024-09-02T12:45:00Z | |
| dc.date.issued | 2024-08-31 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 9 | |
| dc.format.extent | 1174879 | |
| dc.identifier | 293060601 | |
| dc.identifier | 8cf49ea3-c35f-45a1-b7bf-9d212258ef40 | |
| dc.identifier | 39215336 | |
| dc.identifier | 85202773007 | |
| dc.identifier.citation | Phillips, R, Bi, D, Goulão, B, Miller, M, El-Askary, M, Fagbemi, O, Freeborn, C, Giammetta, M, El Masri, N, Flockhart, P, Kumar, M, Melvin, M, Murray, D, Myhill, A, Saeid, L, Thomas, S, MacLennan, G & Cornelius, V 2024, 'Public perspective on potential treatment intervention harm in clinical trials-terminology and communication', Trials, vol. 25, no. 1, 573. https://doi.org/10.1186/s13063-024-08418-w | en |
| dc.identifier.doi | 10.1186/s13063-024-08418-w | |
| dc.identifier.iss | 1 | en |
| dc.identifier.issn | 1745-6215 | |
| dc.identifier.other | PubMedCentral: PMC11365119 | |
| dc.identifier.other | ORCID: /0000-0002-1039-5646/work/166662862 | |
| dc.identifier.uri | https://hdl.handle.net/2164/24147 | |
| dc.identifier.vol | 25 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Trials | en |
| dc.subject | Clinical trials | en |
| dc.subject | Adverse events | en |
| dc.subject | Harms | en |
| dc.subject | Public partners | en |
| dc.subject | Patient and public involvement | en |
| dc.subject | R Medicine | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject | NIHR152365 | en |
| dc.subject | NIHR 22/17 | en |
| dc.subject.lcc | R | en |
| dc.title | Public perspective on potential treatment intervention harm in clinical trials-terminology and communication | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Phillips_etal_T_Public_Perspective_On_VoR.pdf
- Size:
- 1.12 MB
- Format:
- Adobe Portable Document Format
